Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Drug Resistance

Free Subscription Articles published in AIDS Retrieve available abstracts of 96 articles: HTML format

Single Articles

January 2008
1. DI BIAGIO A , Rosso R, Bruzzone B, Cenderello G, et al
   Different evidence of key amprenavir resistance mutations on the efficacy of darunavir.
   AIDS. 2008;22:437-8.
   PubMed     Related articles   
   
   
   
2. MIHAILIDIS C , Dunn D, Pillay D, Pozniak A, et al
   Effect of isolated V118I mutation in reverse transcriptase on response to first-line antiretroviral therapy.
   AIDS. 2008;22:427-30.
   PubMed     Related articles    Abstract available
   
   
   
3. DELFRAISSY JF , Flandre P, Delaugerre C, Ghosn J, et al
   Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients.
   AIDS. 2008;22:385-93.
   PubMed     Related articles    Abstract available
   
   
   
4. BANNISTER WP , Ruiz L, Cozzi-Lepri A, Mocroft A, et al
   Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA.
   AIDS. 2008;22:367-76.
   PubMed     Related articles    Abstract available
   
   
   
5. DE MENDOZA C , Garrido C, Corral A, Zahonero N, et al
   Prevalence and impact of HIV-1 protease mutation L76V on lopinavir resistance.
   AIDS. 2008;22:311-3.
   PubMed     Related articles    Abstract available
   
   
   
6. HO TSONG FANG R , Colantonio AD, Uittenbogaart CH
   The role of the thymus in HIV infection: a 10 year perspective.
   AIDS. 2008;22:171-84.
   PubMed     Related articles   
   
   
   
7. PICCHIO G , De Meyer S, de Bethune MP
   Response to "key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients".
   AIDS. 2008;22:165-7.
   PubMed     Related articles   
   
   
   
8. GARDNER EM , Sharma S, Peng G, Hullsiek KH, et al
   Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance.
   AIDS. 2008;22:75-82.
   PubMed     Related articles    Abstract available
   
   
   December 2007
9. ZHANG X , Li S, Li X, Li X, et al
   Characterization of HIV-1 subtypes and viral antiretroviral drug resistance in men who have sex with men in Beijing, China.
   AIDS. 2007;21 Suppl 8:S59-65.
   PubMed     Related articles    Abstract available
   
   
   
10. ZHANG F , Haberer JE, Wang Y, Zhao Y, et al
    The Chinese free antiretroviral treatment program: challenges and responses.
    AIDS. 2007;21 Suppl 8:S143-8.
    PubMed     Related articles    Abstract available
    
    
    November 2007
11. TAMALET C , Tomei C, Henry M, Solas C, et al
    Selection of L74V mutation in reverse transcriptase of HIV-1 subtype D by a tenofovir DF-lamivudine based regimen.
    AIDS. 2007;21:2551-2552.
    PubMed     Related articles   
    
    
    
12. MELBY TE , Despirito M, Demasi RA, Heilek G, et al
    Association between specific enfuvirtide resistance mutations and CD4 cell response during enfuvirtide-based therapy.
    AIDS. 2007;21:2537-9.
    PubMed     Related articles    Abstract available
    
    
    
13. MASCIOTRA S , Garrido C, Youngpairoj AS, McNulty A, et al
    High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
    AIDS. 2007;21:2503-2511.
    PubMed     Related articles    Abstract available
    
    
    
14. CRABB C
    More sensitive assay to detect drug-resistant HIV.
    AIDS. 2007;21:N3.
    PubMed     Related articles   
    
    
    
15. MARCELIN AG , Jarrousse B, Derache A, Ba M, et al
    HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen.
    AIDS. 2007;21:2341-3.
    PubMed     Related articles    Abstract available
    
    
    October 2007
16. WALMSLEY SL , Cotte L, Rusconi S, Ward DJ, et al
    Treatment response to ritonavir-boosted tipranavir versus ritonavir-boosted lopinavir in HIV-1 patients with higher lopinavir mutation scores.
    AIDS. 2007;21:2245-8.
    PubMed     Related articles    Abstract available
    
    
    
17. YERLY S , von Wyl V, Ledergerber B, Boni J, et al
    Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.
    AIDS. 2007;21:2223-9.
    PubMed     Related articles    Abstract available
    
    
    
18. PAREDES R , Cheng I, Kuritzkes DR, Tuomala RE, et al
    High prevalence of primary lamivudine and nelfinavir resistance in HIV-1-infected pregnant women in the United States, 1998-2004.
    AIDS. 2007;21:2103-2106.
    PubMed     Related articles    Abstract available
    
    
    
19. FLYS TS , Mwatha A, Guay LA, Nakabiito C, et al
    Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine.
    AIDS. 2007;21:2077-2082.
    PubMed     Related articles    Abstract available
    
    
    
20. FOX ZV , Geretti AM, Kjaer J, Dragsted UB, et al
    The ability of four genotypic interpretation systems to predict virological response to ritonavir-boosted protease inhibitors.
    AIDS. 2007;21:2033-2042.
    PubMed     Related articles    Abstract available
    
    
    
21. MARGOLIS DM , Mukherjee AL, Fletcher CV, Hogg E, et al
    The use of beta-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infection.
    AIDS. 2007;21:2025-2032.
    PubMed     Related articles    Abstract available
    
    
    September 2007
22. CHIBO D , Roth N, Roulet V, Skrabal K, et al
    Virological fitness of HIV in patients with resistance to enfuvirtide.
    AIDS. 2007;21:1974-1977.
    PubMed     Related articles    Abstract available
    
    
    August 2007
23. STEBBING J , Nathan B, Jones R, McKenna A, et al
    Virological failure and subsequent resistance profiles in individuals exposed to atazanavir.
    AIDS. 2007;21:1826-8.
    PubMed     Related articles    Abstract available
    
    
    
24. MAURO Z , Federica F, Patrizia L, Francesca CS, et al
    Continuous evidence of fast HIV disease progression related to class-wide resistance to antiretroviral drugs: a 6 year follow-up analysis of a large observational database.
    AIDS. 2007;21:1824-1826.
    PubMed     Related articles    Abstract available
    
    
    
25. GARRETT NJ , Matin N, Edwards SG, Miller RF, et al
    Efficacy of boosted protease inhibitor monotherapy in patients with complex medical problems.
    AIDS. 2007;21:1821-3.
    PubMed     Related articles    Abstract available
    
    
    July 2007
26. PETERSEN ML , Wang Y, van der Laan MJ, Rhee SY, et al
    Virologic efficacy of boosted double versus boosted single protease inhibitor therapy.
    AIDS. 2007;21:1547-1554.
    PubMed     Related articles    Abstract available
    
    
    
27. LEDERMAN MM , Miller V, Weller I, Deeks SG, et al
    A new approach for 'deep salvage' trials in advanced HIV infection.
    AIDS. 2007;21:1503-1506.
    PubMed     Related articles    Abstract available
    
    
    
28. TORTOLI E , Galli L, Andebirhan T, Baruzzo S, et al
    The first case of Mycobacterium sherrisii disseminated infection in a child with AIDS.
    AIDS. 2007;21:1496-8.
    PubMed     Related articles   
    
    
    
29. BOFFITO M , Winston A, Jackson A, Fletcher C, et al
    Pharmacokinetics and antiretroviral response to darunavir/ritonavir and etravirine combination in patients with high-level viral resistance.
    AIDS. 2007;21:1449-1455.
    PubMed     Related articles    Abstract available
    
    
    
30. PARIKH UM , Zelina S, Sluis-Cremer N, Mellors JW, et al
    Molecular mechanisms of bidirectional antagonism between K65R and thymidine analog mutations in HIV-1 reverse transcriptase.
    AIDS. 2007;21:1405-14.
    PubMed     Related articles    Abstract available
    
    
    
31. DUNNE M
    Antiretroviral drug development: the challenge of cost and access.
    AIDS. 2007;21 Suppl 4:S73-9.
    PubMed     Related articles    Abstract available
    
    
    June 2007
32. LANZAFAME M , Lattuada E, Gottardi M, Antolini D, et al
    Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption.
    AIDS. 2007;21:1384-6.
    PubMed     Related articles   
    
    
    
33. DELAUGERRE C , Marcelin AG, Soulie C, Chaix ML, et al
    Transmission of multidrug-resistant HIV-1: 5 years of immunological and virological survey.
    AIDS. 2007;21:1365-1367.
    PubMed     Related articles    Abstract available
    
    
    
34. DILERNIA DA , Lourtau L, Gomez AM, Ebenrstejin J, et al
    Drug-resistance surveillance among newly HIV-1 diagnosed individuals in Buenos Aires, Argentina.
    AIDS. 2007;21:1355-1360.
    PubMed     Related articles    Abstract available
    
    
    May 2007
35. DELAUGERRE C , Mathez D, Peytavin G, Berthe H, et al
    Key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients.
    AIDS. 2007;21:1210-1213.
    PubMed     Related articles    Abstract available
    
    
    
36. VEKEMANS M , John L, Colebunders R
    When to switch for antiretroviral treatment failure in resource-limited settings?
    AIDS. 2007;21:1205-6.
    PubMed     Related articles   
    
    
    
37. ESHLEMAN SH , Husnik M, Hudelson S, Donnell D, et al
    Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection.
    AIDS. 2007;21:1165-1174.
    PubMed     Related articles    Abstract available
    
    
    
38. SEYLER C , Adje-Toure C, Messou E, Dakoury-Dogbo N, et al
    Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa.
    AIDS. 2007;21:1157-1164.
    PubMed     Related articles    Abstract available
    
    
    
39. CARRIERI MP , Spire B
    'Forced treatment interruptions' and risk of HIV resistance in countries adopting law enforcement against marginalized populations.
    AIDS. 2007;21:1062-1063.
    PubMed     Related articles   
    
    
    
40. 
    Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom.
    AIDS. 2007;21:1035-9.
    PubMed     Related articles    Abstract available
    
    
    
41. WALENSKY RP , Weinstein MC, Yazdanpanah Y, Losina E, et al
    HIV drug resistance surveillance for prioritizing treatment in resource-limited settings.
    AIDS. 2007;21:973-982.
    PubMed     Related articles    Abstract available
    
    
    
42. OYUGI JH , Byakika-Tusiime J, Ragland K, Laeyendecker O, et al
    Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda.
    AIDS. 2007;21:965-971.
    PubMed     Related articles    Abstract available
    
    
    
43. 
    Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children.
    AIDS. 2007;21:947-55.
    PubMed     Related articles    Abstract available
    
    
    April 2007
44. DARGERE S , Parienti JJ, Verdon R
    Treatment resistance after sequential interruption of a non-nucleoside reverse transcriptase inhibitor-based regimen.
    AIDS. 2007;21:879-80.
    PubMed     Related articles   
    
    
    
45. MALET I , Wirden M, Derache A, Simon A, et al
    Primary genotypic resistance of HIV-1 to the maturation inhibitor PA-457 in protease inhibitor-experienced patients.
    AIDS. 2007;21:871-873.
    PubMed     Related articles    Abstract available
    
    
    
46. NAPRAVNIK S , Keys JR, Quinlivan EB, Wohl DA, et al
    Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients.
    AIDS. 2007;21:825-34.
    PubMed     Related articles    Abstract available
    
    
    
47. GULICK RM , Lalama CM, Ribaudo HJ, Shikuma CM, et al
    Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression.
    AIDS. 2007;21:813-823.
    PubMed     Related articles    Abstract available
    
    
    March 2007
48. LAURENT C , Kouanfack C, Koulla-Shiro S, Njoume M, et al
    Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine.
    AIDS. 2007;21:768-771.
    PubMed     Related articles    Abstract available
    
    
    
49. CHAPPELL BJ , Margot NA, Miller MD
    Long-term follow-up of patients taking tenofovir DF with low-level HIV-1 viremia and the K65R substitution in HIV-1 RT.
    AIDS. 2007;21:761-3.
    PubMed     Related articles    Abstract available
    
    
    
50. COZZI-LEPRI A , Phillips AN, Ruiz L, Clotet B, et al
    Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.
    AIDS. 2007;21:721-732.
    PubMed     Related articles    Abstract available
    
    
    
51. METZNER KJ , Allers K, Rauch P, Harrer T, et al
    Rapid selection of drug-resistant HIV-1 during the first months of suppressive ART in treatment-naive patients.
    AIDS. 2007;21:703-11.
    PubMed     Related articles    Abstract available
    
    
    
52. FRANKEL FA , Invernizzi CF, Oliveira M, Wainberg MA, et al
    Diminished efficiency of HIV-1 reverse transcriptase containing the K65R and M184V drug resistance mutations.
    AIDS. 2007;21:665-75.
    PubMed     Related articles    Abstract available
    
    
    
53. HAUBRICH R , Berger D, Chiliade P, Colson A, et al
    Week 24 efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients.
    AIDS. 2007;21:F11-F18.
    PubMed     Related articles    Abstract available
    
    
    
54. 
    Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis.
    AIDS. 2007;21:F1-F10.
    PubMed     Related articles    Abstract available
    
    
    February 2007
55. TOLSTRUP M , Selzer-Plon J, Laursen AL, Bertelsen L, et al
    Full fusion competence rescue of the enfuvirtide resistant HIV-1 gp41 genotype (43D) by a prevalent polymorphism (137K).
    AIDS. 2007;21:519-521.
    PubMed     Related articles   
    
    
    
56. MARCHOU B , Tangre P, Charreau I, Izopet J, et al
    Intermittent antiretroviral therapy in patients with controlled HIV infection.
    AIDS. 2007;21:457-66.
    PubMed     Related articles    Abstract available
    
    
    
57. CANE PA , Green H, Fearnhill E, Dunn D, et al
    Identification of accessory mutations associated with high-level resistance in HIV-1 reverse transcriptase.
    AIDS. 2007;21:447-55.
    PubMed     Related articles    Abstract available
    
    
    January 2007
58. FISCHL MA , Collier AC, Mukherjee AL, Feinberg JE, et al
    Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen.
    AIDS. 2007;21:325-333.
    PubMed     Related articles    Abstract available
    
    
    
59. MILLER MD , Margot N, McColl D, Cheng AK, et al
    K65R development among subtype C HIV-1-infected patients in tenofovir DF clinical trials.
    AIDS. 2007;21:265-6.
    PubMed     Related articles   
    
    
    
60. HASTINGS IM , Lalloo DG, Khoo SH
    Continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?'.
    AIDS. 2007;21:258-9.
    PubMed     Related articles   
    
    
    
61. RAGUIN G , Poizat G, Morand-Joubert L, Taburet AM, et al
    Salvage therapy with amprenavir, lopinavir and ritonavir is durably potent in HIV-infected patients in virological failure: 1-year results.
    AIDS. 2007;21:241-243.
    PubMed     Related articles    Abstract available
    
    
    
62. COLFAX GN , Vittinghoff E, Grant R, Lum P, et al
    Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance.
    AIDS. 2007;21:239-241.
    PubMed     Related articles    Abstract available
    
    
    
63. FOX J , Hill S, Kaye S, Dustan S, et al
    Prevalence of primary genotypic resistance in a UK centre: comparison of primary HIV-1 and newly diagnosed treatment-naive individuals.
    AIDS. 2007;21:237-239.
    PubMed     Related articles    Abstract available
    
    
    
64. SHAFER RW , Rhee SY, Pillay D, Miller V, et al
    HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.
    AIDS. 2007;21:215-223.
    PubMed     Related articles    Abstract available
    
    
    
65. DURAN AS , Losso MH, Salomon H, Harris DR, et al
    Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis.
    AIDS. 2007;21:199-205.
    PubMed     Related articles    Abstract available
    
    
    
66. NAEGER LK , Struble KA
    Food and Drug Administration analysis of tipranavir clinical resistance in HIV-1-infected treatment-experienced patients.
    AIDS. 2007;21:179-85.
    PubMed     Related articles    Abstract available
    
    
    
67. ANANWORANICH J , Hirschel B
    Intermittent therapy for the treatment of chronic HIV infection.
    AIDS. 2007;21:123-134.
    PubMed     Related articles   
    
    
    
68. JOKELA JA , Kaur P
    Caspofungin-resistant oral and esophageal candidiasis in a patient with AIDS.
    AIDS. 2007;21:118-9.
    PubMed     Related articles   
    
    
    
69. MASQUELIER B , Capdepont S, Neau D, Peuchant O, et al
    Virological characterization of an infection with a dual-tropic, multidrug-resistant HIV-1 and further evolution on antiretroviral therapy.
    AIDS. 2007;21:103-106.
    PubMed     Related articles    Abstract available
    
    
    
70. MULENGA V , Ford D, Walker AS, Mwenya D, et al
    Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children.
    AIDS. 2007;21:77-84.
    PubMed     Related articles    Abstract available
    
    
    November 2006
71. MCKINNON JE , Arribas JR, Pulido F, Delgado R, et al
    The level of persistent HIV viremia does not increase after successful simplification of maintenance therapy to lopinavir/ritonavir alone.
    AIDS. 2006;20:2331-5.
    PubMed     Related articles    Abstract available
    
    
    
72. NEIFER S , Somogyi S, Schlote F, Berg T, et al
    Persistence of a sexually transmitted highly resistant HIV-1: pol quasispecies evolution over 33 months in the absence of treatment.
    AIDS. 2006;20:2231-3.
    PubMed     Related articles    Abstract available
    
    
    
73. LACOMBE K , Ollivet A, Gozlan J, Durantel S, et al
    A novel hepatitis B virus mutation with resistance to adefovir but not to tenofovir in an HIV-hepatitis B virus-co-infected patient.
    AIDS. 2006;20:2229-2231.
    PubMed     Related articles    Abstract available
    
    
    
74. TRUONG HH , Grant RM, McFarland W, Kellogg T, et al
    Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance.
    AIDS. 2006;20:2193-7.
    PubMed     Related articles    Abstract available
    
    
    October 2006
75. FLANDRE P , Costagliola D
    On the comparison of artificial network and interpretation systems based on genotype resistance mutations in HIV-1-infected patients.
    AIDS. 2006;20:2118-20.
    PubMed     Related articles    Abstract available
    
    
    
76. GRUBB JR , Singhatiraj E, Mondy K, Powderly WG, et al
    Patterns of primary antiretroviral drug resistance in antiretroviral-naive HIV-1-infected individuals in a midwest university clinic.
    AIDS. 2006;20:2115-6.
    PubMed     Related articles    Abstract available
    
    
    
77. CABRERA C , Marfil S, Garcia E, Martinez-Picado J, et al
    Genetic evolution of gp41 reveals a highly exclusive relationship between codons 36, 38 and 43 in gp41 under long-term enfuvirtide-containing salvage regimen.
    AIDS. 2006;20:2075-2080.
    PubMed     Related articles    Abstract available
    
    
    
78. KAN VL , Gale HB, Shinol RC
    Response to Waters et al. 'Successful use of genotypic resistance testing in HIV-1-infected individuals with detectable viraemia ...'.
    AIDS. 2006;20:1991-2.
    PubMed     Related articles   
    
    
    
79. SCHMUTZ G , Nelson M, Lutz T, Sheldon J, et al
    Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection.
    AIDS. 2006;20:1951-1954.
    PubMed     Related articles    Abstract available
    
    
    September 2006
80. BONJOCH A , Negredo E, Puig J, Erkizia I, et al
    Viral failure in HIV-infected patients with long-lasting viral suppression who discontinued enfuvirtide.
    AIDS. 2006;20:1896-8.
    PubMed     Related articles    Abstract available
    
    
    August 2006
81. BAUER GR , Colgrove RC, Larussa PS, Pitt J, et al
    Antiretroviral resistance in viral isolates from HIV-1-transmitting mothers and their infants.
    AIDS. 2006;20:1707-1712.
    PubMed     Related articles    Abstract available
    
    
    July 2006
82. BARBER TJ
    Response to Waters et al. 'Successful use of genotypic resistance testing in HIV-1-infected individuals with detectable viraemia between 50 and 1000 copies/ml'.
    AIDS. 2006;20:1565.
    PubMed     Related articles   
    
    
    
83. PAO D , Smit E, Imami N, Fisher M, et al
    A case of multidrug resistant primary HIV infection with delayed CD4 T-cell count decline despite low viral load, treated with interleukin-2.
    AIDS. 2006;20:1564-1565.
    PubMed     Related articles   
    
    
    
84. JULG B , Bogner JR, Goebel FD
    Severe hepatotoxicity associated with the combination of enfuvirtide and tipranavir/ritonavir: case report.
    AIDS. 2006;20:1563.
    PubMed     Related articles   
    
    
    
85. POVEDA E , Blanco F, Garcia-Gasco P, Alcolea A, et al
    Successful rescue therapy with darunabir (TMC114) in HIV-infected patients who have failed several ritonavir-boosted protease inhibitors.
    AIDS. 2006;20:1558-60.
    PubMed     Related articles    Abstract available
    
    
    
86. GIFFORD R , de Oliveira T, Rambaut A, Myers RE, et al
    Assessment of automated genotyping protocols as tools for surveillance of HIV-1 genetic diversity.
    AIDS. 2006;20:1521-1529.
    PubMed     Related articles    Abstract available
    
    
    
87. BERKHOUT B , Back NK, de Ronde A, Jurriaans S, et al
    Identification of alternative amino acid substitutions in drug-resistant variants of the HIV-1 reverse transcriptase.
    AIDS. 2006;20:1515-20.
    PubMed     Related articles    Abstract available
    
    
    June 2006
88. HASTINGS IM , Lalloo D, Khoo SH
    Will ART rollout in Africa drive an epidemic of drug resistant HIV?
    AIDS. 2006;20:1354-6.
    PubMed     Related articles   
    
    
    
89. PARISI SG , Mazzi R, Boldrin C, Dal Bello F, et al
    Drug-resistance mutations can be archived very early in HIV primary infection.
    AIDS. 2006;20:1337-8.
    PubMed     Related articles   
    
    
    
90. SHAPIRO RL , Thior I, Gilbert PB, Lockman S, et al
    Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana.
    AIDS. 2006;20:1281-1288.
    PubMed     Related articles    Abstract available
    
    
    
91. BRENNER BG , Oliveira M, Doualla-Bell F, Moisi DD, et al
    HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture.
    AIDS. 2006;20:F9-F13.
    PubMed     Related articles    Abstract available
    
    
    February 2006
92. SORIANO V , Sheldon J, Ramos B, Nunez M, et al
    Confronting chronic hepatitis B virus infection in HIV: new diagnostic tools and more weapons.
    AIDS. 2006;20:451-3.
    PubMed     Related articles   
    
    
    January 2006
93. BRENNAN-BENSON P , Pakianathan M, Rice P, Bonora S, et al
    Enfurvitide prevents vertical transmission of multidrug-resistant HIV-1 in pregnancy but does not cross the placenta.
    AIDS. 2006;20:297-299.
    PubMed     Related articles    Abstract available
    
    
    
94. ROQUEBERT B , Malet I, Wirden M, Tubiana R, et al
    Role of HIV-1 minority populations on resistance mutational pattern evolution and susceptibility to protease inhibitors.
    AIDS. 2006;20:287-9.
    PubMed     Related articles    Abstract available
    
    
    
95. BANGSBERG DR , Acosta EP, Gupta R, Guzman D, et al
    Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness.
    AIDS. 2006;20:223-31.
    PubMed     Related articles    Abstract available
    
    
    
96. GHOSN J , Pellegrin I, Goujard C, Deveau C, et al
    HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time.
    AIDS. 2006;20:159-170.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: